Switch to
View more

Ajanta Pharma Ltd

AJANTPHARM
Health CarePharmaceuticals
MidcapWith a market cap of ₹15,981 cr, stock is ranked 240
Low RiskStock is 1.57x as volatile as Nifty
1,247.3528.25 (+2.32%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹15,981 cr, stock is ranked 240
Low RiskStock is 1.57x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
22.42
PB RatioPB Ratio
5.34
Dividend YieldDiv. Yield
0.78%
Sector PESector PE
32.85
Sector PBSector PB
4.55
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

91%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20192020202120222.082.682.923.460.390.470.650.71
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Bonus 
Announced OnJun 24, 2022

The Company has allotted 4,27,08,385 Bonus Equity Shares of Rs. 2/- each as fully-paid up Bonus Equity Shares, in the proportion of 1:2, to the eligible Members whose names appeared on the register of Members/list of beneficial owners as on 23rd June 2022, i.e. record date fixed for this purpose.Consequently, the paid-up Equity Share Capital of the Company stands increased from Rs. 17,08,33,540 divided into 8,54,16,770 Equity Shares of Rs. 2/- each to Rs. 25,62,50,310 divided into 12,81,25,155 Equity Shares of Rs. 2/- each.As part of the aforesaid allotment 14,758 Bonus Equity Shares representing fractional entitlement(s) of eligible Members have been consolidated and allotted to a separate account opened for this purpose. Such equity shares would be sold at the prevailing market rate as soon as possible and the net sale proceeds after adjusting the cost and expenses in respect thereof, would be distributed amongst the members as per their respective fractional entitlements. | Download

The Company has allotted 4,27,08,385 Bonus Equity Shares of Rs. 2/- each as fully-paid up Bonus Equity Shares, in the proportion of 1:2, to the eligible Members whose names appeared on the register of Members/list of beneficial owners as on 23rd June 2022, i.e. record date fixed for this purpose.Consequently, the paid-up Equity Share Capital of the Company stands increased from Rs. 17,08,33,540 divided into 8,54,16,770 Equity Shares of Rs. 2/- each to Rs. 25,62,50,310 divided into 12,81,25,155 Equity Shares of Rs. 2/- each.As part of the aforesaid allotment 14,758 Bonus Equity Shares representing fractional entitlement(s) of eligible Members have been consolidated and allotted to a separate account opened for this purpose. Such equity shares would be sold at the prevailing market rate as soon as possible and the net sale proceeds after adjusting the cost and expenses in respect thereof, would be distributed amongst the members as per their respective fractional entitlements. | Download

General updates 
Announced OnJun 21, 2022

Ajanta Pharma Limited has informed the Exchange about Intimation of AGM | Download

Ajanta Pharma Limited has informed the Exchange about Intimation of AGM | Download

Cash Dividend 
Ex. DateNov 9, 2021

Interim • Div/Share: ₹ 9.5

See all events